TPG Group Holdings (SBS) Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-453,128	Closed	-$43.6M	–	47
2015 Q3	$43.6M	Sell	453,128 -143,292	-24%	-$16.4M	0.21%	23
2015 Q2	$61.1M	Sell	596,420 -1,000,000	-63%	-$77.6M	0.28%	14
2015 Q1	$99.1M	Sell	1,596,420 -500,000	-24%	-$27.8M	0.5%	11
2014 Q4	$92M	Sell	2,096,420 -500,000	-19%	-$22.9M	0.56%	11
2014 Q3	$147M	Sell	2,596,420 -488,820	-16%	-$24.6M	0.99%	10
2014 Q2	$138M	Hold	3,085,240	–	–	0.86%	12
2014 Q1	$151M	Buy	+3,085,240	New	+$159M	1.59%	11

Other funds holding RARE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's RARE Position: Q4 2015 in Review

TPG Group Holdings (SBS) Advisors sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2015, closing a stake of 453,128 shares — an estimated $43.6M sold.

TPG Group Holdings (SBS) Advisors first reported a position in RARE in Q1 2014 and held it in 7 quarters. The position peaked at $151M in Q1 2014. 171 funds tracked by Wall St. Rank hold RARE as of Q4 2015.

TPG Group Holdings (SBS) Advisors reported no remaining Ultragenyx Pharmaceutical position as of Q4 2015 after selling out during the quarter.
TPG Group Holdings (SBS) Advisors sold 453,128 Ultragenyx Pharmaceutical shares in Q4 2015, an estimated $43.6M.
TPG Group Holdings (SBS) Advisors first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 7 quarters.
TPG Group Holdings (SBS) Advisors's Ultragenyx Pharmaceutical position peaked at $151M in Q1 2014.
171 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2015.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.